New data link GLP-1 receptor agonists to lower knee replacement risk in osteoarthritis. Read more to explore the clinical implications.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.